Cleared Traditional

K160156 - StatStrip Xpress Blood Glucose Monitoring System

K160156 is an FDA 510(k) clearance for StatStrip Xpress Blood Glucose Monitori..., manufactured by Nova Biomedical Corporation. The device is a Class 2 Chemistry device with product code NBW cleared through the Traditional 510(k) pathway after a 153-day FDA review.

K160156 · Nova Biomedical Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2016
Decision
153d
Days
Class 2
Risk

K160156 is an FDA 510(k) clearance for the StatStrip Xpress Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on June 23, 2016 after a review of 153 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Nova Biomedical Corporation devices

FDA 510(k) Submission Details - K160156

510(k) Number K160156 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2016
Decision Date June 23, 2016
Days to Decision 153 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d slower than avg
Panel avg: 88d · This submission: 153d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 420
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K160156.
PRODIGY ASTRO Blood Glucose Monitoring System, PRODIGY ASTRO PRO Blood Glucose Monitoring System
K152599 · Ok Biotech Co., Ltd. · Jul 2016
SD GlucoNavii Mentor BT Blood Glucose Monitoring System, SD GlucoNavii Mentor BT Multi Blood Glucose Monitoring System
K153201 · Sd Biosensor · Jun 2016
Contour Next Link Wireless Blood Glucose Monitoring System, Contour Next Blood Glucose Monitoring System
K160430 · Ascensia Diabetes Care U.S., Inc. · Jun 2016
POGO Automatic Blood Glucose Monitoring System
K152493 · Intuity Medical, Inc. · Apr 2016
AgaMatrix Jazz Wireless 2 Blood Glucose Monitoring System
K152365 · Agamatrix, Inc. · Apr 2016
TRUE METRIX GO Self Monitoring Blood Glucose System
K143548 · Trividia Health, Inc. · Apr 2016